Rating:
Aum
₹1,511.49 Cr
Expense Ratio
2.37%
Exit Load
0.25%
Min. Investment
₹5,000.00
Min. SIP
₹100.00
Launch Date
28 Dec 2015
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +2.6% | -- |
| 3 Months | -3.55% | -- |
| 6 Months | +6.69% | -- |
| 1 Year | +5.22% | +5.22% |
| 2 Years | -- | +3.24% |
| 3 Years | +63.95% | +17.92% |
| 5 Years | +88.65% | +13.54% |
| Since Launch | +226.61% | +11.52% |
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 120.84 | 7.99 |
| Abbott India | 89.75 | 5.94 |
| HealthCare Global Enterprises Ltd | 89.52 | 5.92 |
| Divi's Laboratories | 85.82 | 5.68 |
| Dr Reddy's Laboratories | 70.32 | 4.65 |
| Apollo Hospitals Enterprise | 65.91 | 4.36 |
| Rainbow Children's Medicare | 65.07 | 4.30 |
| Cipla | 63.79 | 4.22 |
| Torrent Pharmaceuticals | 56.89 | 3.76 |
| Max Healthcare Institute | 56.10 | 3.71 |
Rating:
Risk
Return
0.65
Sharpe Ratio
16.71%
Std. Deviation
10.07%
Tracking Error
11.23%
Alpha
0.70
Beta
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | +16.17% | +23.25% | +15.72% |
| Mirae Asset Healthcare Fund Regular Growth | +20.29% | +22.85% | +15.33% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth | +15.64% | +20.01% | +13.75% |
| Tata India Pharma & Healthcare Fund Regular Growth | +5.22% | +17.92% | +13.54% |
| HDFC Pharma and Healthcare Fund Regular Growth | +24.81% | +29.79% | -- |
Results are calculated on CAGR basis
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1511.49 crores & has delivered CAGR of 13.54 in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 2.37%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.
As per morningstar the risk & return rating of the fund are Medium & High respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Abbott India, HealthCare Global Enterprises Ltd, Divi's Laboratories.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing, Major Drugs.
Some of the similar funds are UTI Healthcare Fund Regular Plan Growth, Mirae Asset Healthcare Fund Regular Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, Tata India Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.65 & a standard deviation of 16.71%.
According to the morning star rating Tata India Pharma & Healthcare Fund Regular Growth has a Medium risk & High return.
Tata India Pharma & Healthcare Fund Regular Growth is managed by Rajat Srivastava.
The expense ratio of Tata India Pharma & Healthcare Fund Regular Growth is 2.37%.
The 5 year annualized return on Tata India Pharma & Healthcare Fund Regular Growth is 13.54% & it has generated 5.22% in the last 1 year.
The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is 5000 Rs.
Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1511.49 crores.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.